News › Clinical Practice, Industry News, Patient Care

Merz Announces New Five-year FDA Indication for Cellulite Treatment

October 28, 2019

Merz has announced that the U.S. Food and Drug Administration (FDA) has cleared Cellfina’s new indication statement that shows the benefits of Cellfina last for five years, an increase from the previous three-year indication. Cellfina demonstrated five-year improvement in the appearance of cellulite on the buttocks and thighs of adult females. The FDA clearance is supported by clinical data demonstrating treatment benefits through five years of observation, making it the longest-lasting cellulite treatment on the market cleared by the FDA.Read more from Merz >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • New Radiesse Research Highlights Deeper Extracellular Matrix Regeneration
    • Aesthetic Injector Academy Becomes Silver Vendor Affiliate with the American Med Spa Association
    • Medical Purchasing Resource Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • How to Implement BHRT in Your Med Spa in 6 Steps
    • Designed by Stax Becomes Platinum Vendor Affiliate with the American Med Spa Association